合一生技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Guo,Xian-Shou
統一編號
29108260
成立日期
2008/06/09
資本額
NT$6,000,000,000
實收資本額
NT$4,792,964,860
股票代號
4743
電話
02-27031098
地址
35F, No. 66, Sec. 1, Zhongsiao W. Rd., Zhongzheng Dist., Taipei City, 100, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Guo,Xian-Shou Chairman 0.00%
Lin,Yi-Fu Director 0.00%
Guo,Tu-Mu Director 0.00%
Huang,San-Gui Independent Director 0.00%
Wu,Rui-Yu Independent Director 0.00%
Lu,Sui Independent Director 0.00%
Huang,Rui-Wen Independent Director 0.00%
營業項目
  • Wholesale of Pharmaceutical and Medical Goods(457111)
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Other Food(454999)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Person in Charge to Guo,Xian-Shou
    2024/06/07
  • Change Capital to 6,000,000,000
    2020/07/10
  • Change Capital to 5,000,000,000
    2019/06/06
  • Change Person in Charge to Huang,Shan-Nei
    2015/07/17
  • Change Person in Charge to Ke,Feng-Nian
    2013/04/11
  • Change Person in Charge to Lin,Wen-Yuan
    2012/01/02
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 25,217 117,926 86,783
    Operating cost 18,105 54,892 54,221
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 7,112 63,034 32,562
    Unrealized profit (loss) on sales of goods - 632 -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 7,112 62,402 32,562
    Operating expenses 197,483 1,148,449 1,129,187
    Other gain (loss), net - - -
    Operating profit (loss) -190,371 -1,086,047 -1,096,625
    Non-operating income and expenses 24,163 -63,683 -220,653
    Net profit (loss) before tax -166,208 -1,149,730 -1,317,278
    Income tax expense (benefits) 116 3,289 5,290
    Net profit (loss) of ongoing business for the current period -166,324 -1,153,019 -1,322,568
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -166,324 -1,153,019 -1,322,568
    Other comprehensive profit (loss), net -562,584 -662,489 21,477
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -728,908 -1,815,508 -1,301,091
    Net profit (loss) attributable to owners of parent company -162,321 -1,165,147 -1,312,867
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -4,003 12,128 -9,701
    Comprehensive profit (loss) attributable to owners of parent company -734,116 -1,838,934 -1,300,682
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 5,208 23,426 -409
    Basic earnings per share (yuan) 0 -2 -2
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -41,298 -345,579 -422,176
    Net cash inflows (outflows) from investing activities 2,080,233 544,164 -4,819,650
    Net cash inflow (outflow) from financing activities -4,381 19,703 386,581
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 16,582 16,642 12,888
    Increase (decrease) in cash and cash equivalents in the current period 2,051,136 234,930 -4,842,357
    Beginning balance of cash and cash equivalents 1,047,758 812,828 5,655,185
    Ending balance of cash and cash equivalents 3,098,894 1,047,758 812,828
    項目 2025 2024 2023
    Current asset 7,023,098 7,293,156 8,018,170
    Non-current asset 5,887,611 6,366,390 7,345,533
    Total asset 12,910,709 13,659,546 15,363,703
    Current liability 163,166 182,915 215,361
    Non-current liability 668,550 676,737 651,068
    Total liability 831,716 859,652 866,429
    share capital 4,792,965 4,790,645 4,545,472
    Equity - secruity token - - -
    capital reserve 7,628,409 7,622,722 9,050,192
    retained earning -1,312,913 -1,154,212 -1,266,904
    Other equity 490,085 1,065,500 1,750,222
    Treasury stock -25,777 -25,777 -25,777
    Total equity attributable to owners of parent company 11,572,769 12,298,878 14,053,205
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 506,224 501,016 444,069
    Total Equity 12,078,993 12,799,894 14,497,274
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 1,033,339 1,033,339 984,163
    Net asset value per share 24 25 30
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額 0
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額 0
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    2024 01-03 0~0.5M 0~0.5M
    2023 01-12 0~0.5M 0~0.5M
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    商標
  • Bonvadis
  • Onfleril
  • Fespixon
  • 速必一
  • ImmuEdit Aptamer
  • 綠鬍子
  • 喜樂療 COMPLEHEAL
  • 合一本草 ONENESS
  • 從齒健康
  • 草本護 HERB NURSE
  • 專利
  • 靶向淋巴細胞活化基因3(LAG-3)的核酸適體及其用途
  • 治療IgE介導的過敏性疾病
  • 促進傷口癒合的局部配方
  • 製造具有經修飾的糖苷化作用之重組糖蛋白之方法
  • 到手香萃取物用於製備具抗微生物功效組合物之用途
  • 牛樟芝化合物、製備方法及其用途
  • 類黃酮化合物用於製備傷口癒合組合物之用途
  • 具抗關節炎活性的到手香精萃物
  • 介白素-6抗體及其用途
  • 政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    嘉義樂活有機農園專區委託經營 嘉義縣政府 105/12/16 29000000.0
    裁判書查詢
  • Others
    2020, 2021
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    2017/05/12 Article 24 of the Labor Standards Act; Paragraph 2, Article 32 of the Labor Standards Act
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。